If It Is Registered with the FDA, Is It an Approved Medical Device?

Questions to Ask After "I Have FDA Materials"

In a meeting for the U.S. market entry, a client sends documents containing the registration number.

The file name includes the term "certificate," and the company name matches.

Can we now write "FDA Approval Complete" in the product introduction?

What to first examine is not the appearance of the document but what type of verification material it is.

The fact that company information is registered and the specific pre-market procedures that apply to that product are distinct questions.

If these two questions are handled as one, the sales team and the regulatory personnel may interpret the word "complete" differently.

This article is an explanation for teams comparing U.S. medical device materials for the first time.

It does not classify individual products, determine exemptions, or assess the legality of sales within the U.S.

The following table and operational sequence are MedQraft's own proposals and are not official forms.

Official Guidance Distinguishing Registration and Product Determination

The FDA explicitly states that inclusion in the databases of business registration and device listing does not mean approval, clearance, or authorization of that business or medical device.

The FDA also advises that it does not issue certification letters for registered medical device establishments.

FDA Registration and Listing Important Reminders

Therefore, third-party verification materials should not be read as product licenses issued by the FDA.

This explanation does not imply that all third-party materials have the same nature.

It is essential to differentiate the issuer, verification target, and the original basis.

When verifying paths for each product, it’s more accurate to confirm the actual names of the procedures and decisions rather than grouping everything under the term "FDA certification."

The FDA's consumer guidance separately provides search paths such as Devices@FDA and De Novo search to confirm approval and clearance.

FDA Registration, Certification Expressions and Product Verification Guidance

First Classify Questions Answered by Materials

The responsible person receiving the material can divide the objectives as follows:

Even if multiple pieces of information are contained in one file, separating the claims supported by each piece of information makes subsequent reviews easier.

Received Material or Explanation	Initial Verification Questions	Questions Not Closed by This Material
Registration and Listing Information	Which establishment and device does this information relate to?	What is the pre-market path for this product?
Product Decision Number / Document	What procedure and what decision involves this product?	Does it connect to the claims of what is being sold?
Confirmation Letter Prepared by the Client	Who wrote it, and what is the original source?	Does the author’s explanation align with the official original text?
"FDA Certified" Phrase in Product Literature	What fact does it briefly express?	Could the reader misunderstand it as product approval?

This table is not a criterion for automatically determining the authenticity of documents.

Seeing registration materials does not automatically conclude product review, nor is it appropriate to classify something as false simply because of an unfamiliar format.

It is used to divide the items for initial verification.

Official Lookup Results and Sales Products Comparison

MedQraft's proposed first step is to be specific about the search targets.

Even starting with just the company name, the final goal should reveal what products and what materials it is trying to link.

If the internal product name and external sales name are different, materials explaining that relationship should also be requested.

Next, confirm the received numbers or product names at the official lookup path and record the date and source of the inquiry.

Distinguish between the record of successfully searching and the record of comparing content.

Even if you have saved the screen, if there is no explanation of what was confirmed, the next responsible person will find it difficult to reproduce the judgment.

Product name, model, and intended use are examples of questions for verification.

If the relationships cannot be verified with public information, record it as a relationship needing additional verification rather than presuming it to be aligned.

This article does not assume that the same items appear in all databases.

Even if search results do not come up immediately, do not rush to conclusions.

Due to variations in search terms, types of materials, and pathways applicable to products, further examination may be necessary.

The FDA explains that some devices may be exempt from pre-market submissions, so do not assume that all medical devices will have the same approval number.

Conditions for exemptions and other obligations are individually reviewed items.

FDA, Is It Really ‘FDA Approved’?

Virtual Case: Review of Transactions with Only Registration Materials Received

The situation below is a hypothetical example created for explanation purposes.

It is not a specific case related to an actual customer or company.

A fictional distribution review team received registration-related materials from a supplier.

The company name was confirmed, but the connection between the model listed in the quotation and the paths for each product has not yet been explained.

The sales team wants to include the phrase "FDA Certified" in their introduction.

Practically useful responses here are not about immediately choosing between "approval complete" or "not for sale."

The value lies in separating the confirmed information and remaining questions, then organizing what justification is needed for the phrase to be publicly disclosed.

Review Item	Current Status Example	Next Verification
Issuer of Information	Received registration-related materials from the supplier	Compare original source and nature of material
Company Information	Completed comparison between the inquired company information and provided materials	Record the inquiry date and range of verification
Sales Model	Connection between the quoted model and relevant justification remains unconfirmed	Request product materials that explain the connection
Applicable Path	Pending review of bases for determinations or exemptions	Licensing personnel to confirm the applicable path
Introduction Phrase	Awaiting review of the expression "FDA Certification Complete"	Compare confirmed facts with reader interpretation

"Query Completed" might indicate the progress status for the first two items.

This does not extend to the completion of the entire table unless it is clear where the next verification must occur in which department.

The key takeaway from this example is not to finalize unverified details as sales materials.

Separate Public Statements from Internal Progress Status

Internal memos are places to record detailed status review.

For example, writing "Registered company information confirmed, model-specific path verification pending" provides clarity on the next task.

This does not mean to use that exact sentence as advertising language.

Public statements should be separately reviewed from the claims and justification you wish to convey.

In internal reviews, each sentence can raise the question: "Who, what, and in what scope was confirmed?"

It examines whether company information has been applied to overall performance claims or whether materials for one model have been misapplied to another model.

This article does not provide a list of permissible advertising phrases.

Whether the phrases accurately reflect the scope of the actual product and materials and whether they meet applicable labeling and advertising regulations should be assessed against specific materials.

Pretty certificate images or short English statements do not replace that review.

Record Unresolved Issues with Responsible Persons and Follow-Up Verification

Even if a review form has been made, simply stating "additional verification needed" can halt subsequent tasks.

List the needed materials, the person responsible for requesting them, and what will be compared after receiving a response.

The date for verification is determined by internal work schedules, and this article does not suggest a legal processing deadline.

In the hypothetical case, one could request the supplier to clarify the relationship between sales models and justification materials, then have the regulatory personnel confirm the applicable path before reviewing the sales wording.

Even if one person holds multiple roles in a company, the decision on the confirmed facts and final wording can be separated and recorded.

Recording unresolved items does not have to be viewed as a failure.

Making remaining unknowns apparent makes the purpose of material requests and reviews clearer.

Conversely, prematurely declaring all completed simply because materials were received may eliminate necessary questions for real decision-making.

Questions and Sources to Confirm in the Next Meeting

• Is the material currently held registration information or product-specific decision basis?
• Have you distinguished the author from the official original text?
• What materials did you compare against the sales model and intended use?
• Have you refrained from filling in unverified relationships with assumptions?
• Does the public statement exceed the actual verification scope?
• Has a next responsible person and necessary materials been established for every unresolved issue?

The major preparatory order for overseas expansion is dealt with in Regulatory Questions to Organize Before U.S. and European Market Entry, Before Submission.

If you need to determine how to define the product itself, you can also refer to An Article Discussing the Purpose, Principle, and Performance of Medical Devices.

The institutional explanations in this text reference the three FDA official guidance documents linked above.

The target country is the U.S., and the material verification date is September 22, 2026.

The revised date of each web page is not replaced with the verification date.

This is not a notice of new regulations coming into effect, and it does not address registration timelines, fees, or individual product submission requirements.

Hypothetical cases, review tables, and operational proposals are authored by MedQraft.